Searched for
PRIVATE EQUITY IN PHARMACEUTICALS
Tata Capital Healthcare Fund to exit Linux Laboratories as ChrysCapital buys 20-25% stakePrivate equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...- Stocks in news: Tata Motors, RVNL, Eicher Motors, Mazagon Dock and LupinIndian equity markets experienced volatility, with the Nifty 50 extending its losing streak for four weeks. Escalating US-Iran hostilities ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe Indian market was under pressure on Thursday, particularly at the index level. Rising crude-oil prices are an obvious concern, but dome...
- Prasol Chemicals fixes price band for Rs 500-cr IPO; issue to open on Sep 8Prasol Chemicals will launch its Rs 500-crore Initial Public Offering on September 8. The company has fixed the price band at Rs 643-676 pe...
- Tough task: Staying invested in businesses while ignoring noise called Gulf war; 6 mid-cap stocks with upside potential of up to 23%Trying to time the market turns volatility into something that beats an investor twice: Once on the way down, and once on the way up. So, i...
- Permira to buy 25.71% in Cloudnine Hospitals parent: CCI filingPermira, a leading global private equity firm, is ready to buy a significant stake in Cloudnine Hospitals, which places the parent company'...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- When volatility rises, will you panic or buy? Depends on the watchlist you build now: 5 large-cap stocks with upside potential of up to 32%Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 31%When the Indian market will start to recover in any real sense is still an open question. But one positive is that the broader market indic...
- Yatharth Hospitals draws interest from Aster, Advent as healthcare consolidation heats upAster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate t...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- Indian companies step up acquisitions for AI, technology and talent: CrisilThe ratings agency said mergers and acquisitions are evolving from an occasional growth option into a core strategic tool for companies see...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Exxon, Lyondell among suitors for Shell's US chemical assets, could fetch $8 billion, FT reportsShell is reportedly seeking to sell its U.S. chemical assets for up to eight billion dollars. Several major companies and a private equity ...
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
- Strikes in the Gulf changing rules behind India’s big-money betsIndia Private Equity Investment 2026: Geopolitical risks now shape private equity deal considerations in India. Investors increasingly focu...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Market breadth is important, especially at this point of time. It is a better indicator of both underlying sentiment and what is likely in ...
- FIIs dumped nearly Rs 1 lakh crore worth of these 10 stocks but 8 defied the selloffForeign investors sold nearly Rs 1 lakh crore from ten Indian stocks. Eight of these companies saw their stock prices increase despite the ...
- Why is market falling today? Sensex falls over 450 points, Nifty below 24,450. 4 key factorsOn Tuesday, Indian stock markets experienced a downturn influenced by increasing oil prices and escalating tensions in the Middle East. Nev...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
Load More
